Bio-Thera Claims A World First With Chinese Tocilizumab Approval

Actemra/RoActemra Gets NMPA Nod; Offers Option For COVID-19 Treatment

First Place Gold Medal
Bio-Thera can boast a world first with its tocilizumab approval • Source: Shutterstock

More from Biosimilars

More from Products